Schmallenberg virus: continuing a trend? by Noad R & Brownlie J
© 2013 Noad and Brownlie, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
Virus Adaptation and Treatment 2013:5 11–19
Virus Adaptation and Treatment
Schmallenberg virus: continuing a trend?
Rob Noad
Joe Brownlie
Department of Pathology and 
Pathogen Biology, Royal Veterinary 
College, Hatfield, UK
Correspondence: Rob Noad 
Centre for Emerging Endemic and Exotic 
Diseases, Royal Veterinary College,  
Hawkshead Lane, Hatfield AL9 7TA 
United Kingdom 
Tel +44 017 076 670 62 
Fax +44 017 076 670 51 
Email rnoad@rvc.ac.uk
Abstract: Since its first isolation in Germany in 2011 the Schmallenberg strain of the   Sathuperi 
virus has been detected across northern Europe. The virus is associated with neurological disease, 
abortion, and congenital deformities in ruminants, particularly among sheep and cattle. The 
rapid dissemination of the pathogen is reminiscent of the transmission of another midge-borne 
arbovirus, Bluetongue virus, which also spread to Europe on several separate occasions between 
1998 and 2007. In this review we detail the characteristic features of the Schmallenberg virus 
and consider whether the virus highlights a European vulnerability for other midge-transmitted 
pathogens.
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Schmallenberg virus was first identified by next generation sequencing of complemen-
tary deoxyribonucleic acid (cDNA) prepared from the plasma of cattle with fever and 
reduced milk yield near Schmallenberg in Germany in November 2011.1 Cattle with 
similar clinical signs were also reported at the same time in the Netherlands. Reverse 
transcription-polymerase chain reaction (RT-PCR)-based tests were developed, and 
testing of archive samples revealed no evidence for the presence of the virus before 
2011.2 From December 2011, Schmallenberg virus was associated with an epizootic 
of deformed calves and lambs across Europe with cases in France, Germany, Belgium, 
The Netherlands, the United Kingdom, Switzerland, Luxembourg, Italy, Denmark, and 
Spain.2 Initial sequence analysis placed Schmallenberg virus as a novel virus in the 
Simbu serogroup of the genus Orthobunyavirus in the family Bunyaviridae.1,3 More 
recent sequencing analysis places the Schmallenberg virus within the species of the 
Sathuperi virus.4
The Simbu serogroup contains 25 viral species and is one of the largest serogroups 
within the Orthobunyavirus genus.5–8 Other viruses in the serogroup include the human 
pathogen Oropouche virus, which is mosquito-transmitted and causes a nonfatal 
dengue fever-like illness in the Caribbean and in South America, and Akabane virus, 
which causes epizootic congenital malformations in ruminants (Table 1). Phylogeneti-
cally, Sathuperi virus is the most closely related to Shamonda, Akabane, and Aino 
viruses, which are all transmitted by midges of the Culicoides genus and also cause 
disease in ruminants.4,8 Although insect transmission studies with Schmallenberg 
virus have not yet been reported, the virus has been detected by RT-PCR from pools 
of Culicoides midges within affected areas.9–11 Sathuperi virus has also been reported 
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to be transmitted by midges in Nigeria and Japan.12–14 Since 
Sathuperi virus was originally isolated from Culex spp. 
mosquitoes in the Andhra Pradesh and the Tamil Nadu 
region in India,15 the role of other arthropods, particularly 
mosquitoes, in the transmission of Schmallenberg virus 
cannot be ruled out. However, given the repeated isolation 
of Schmallenberg or Sathuperi viruses from Culicoides spp. 
midges in Europe,9–11 Japan,3,14 and Nigeria,13 it is likely 
that they are also the major vector for Schmallenberg virus 
in Europe.
Clinical signs
As with most viruses that can replicate in multiple hosts, 
disease pathology of Schmallenberg virus is dependent on 
the infected species. Experimental infection of type 1 inter-
feron knockout mice and cattle with Schmallenberg virus 
have both been reported.1,16,17 In the first cattle study, three 
9-month-old calves were inoculated with the virus; one calf 
developed fever (40.5°C) and one had mucous diarrhea.1 
In this study, viral ribonucleic acid (RNA) was detected 
by RT-PCR for 2–5 days postinoculation.1 In the second 
study, eight 9–18-month-old calves were inoculated with 
serum from an experimentally infected animal that showed 
clinical signs (four animals), or 2 × 107 TCID50 virus that 
had been passaged no more than four times in cell culture 
(four animals). Although no animal developed detectable 
fever, and only one animal developed mild diarrhea, all 
virus-inoculated animals developed viraemia detectable for 
5–7 days by real time RT-PCR, and all seroconverted by 
enzyme-linked immunosorbent assay (ELISA) by day 21 
postinoculation.17 Four in-contact control animals that were 
not inoculated with the virus developed neither detectable 
nor seroconverted viraemia.
Although Schmallenberg virus was originally associ-
ated with reduced milk yield and diarrhea in adult cattle, its 
main clinical impact has been related to teratological effects 
when pregnant sheep, cattle, and goats have been infected 
with the virus. Affected fetuses often spontaneously abort 
and can display arthrogryposis, as well as malformations 
of the skull, spinal column, and brain including macro-
cephaly, kyphosis, scoliosis, torticollis, lordosis, cerebellar 
  hypoplasia, hydrocephalus, and porencephaly.18–21 Fetuses 
that go to full term can display a range of clinical signs 
ranging from malformations similar to aborted fetuses to 
morphologically normal animals with neurological signs 
such as ataxia, blindness, paralysis, exaggerated movements, 
and polioencephalomyelitis.20,22 For wild ruminants, there is 
evidence that both red deer and roe deer have been exposed 
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S
Figure  1  Genome  organization  of  the  Schmallenberg  virus.  (A)  The  virus  has 
three  strands  of  negative-sense  single  stranded  RNA  (L,  M,  and  S).  L  encodes 
the  multifunctional  cap  endonuclease-RNA-dependent-RNA-polymerase  enzyme; 
M encodes two glycoproteins, Gn and Gc, and the nonstructural protein, NSm, 
encoded as a polyprotein; S encodes the nucleocapsid (N) and, from an alternative 
frame-shifted  start  codon,  the  nonstructural  protein,  NSs.  All  three  genome 
segments must be transcribed to positive sense RNA before translation is possible. 
Arrows indicate the direction of translation. (B) The genome terminal nucleotides 
of the three segments of the Akabane virus and Schmallenberg virus.
Notes: Like other bunyaviruses, the terminal sequences of Akabane are conserved 
between segments and are complementary. Current sequences for the Schmallenberg 
virus do not match this pattern.
Abbreviations: RNA, ribonucleic acid; L, large; M, medium; S, small.
to Schmallenberg virus and develop an antibody response.23 
However, in this study, there was no evidence for viral RNA 
in deer or epizootics of congenital malformations. There is 
also evidence that alpacas kept in areas where Schmallenberg 
virus is circulating tend to develop an antibody response 
to the virus,24 although, to our knowledge, no confirmed 
cases of clinical disease have been reported in alpacas or 
other camelids.
The clinical signs of Schmallenberg virus infection 
in sheep, cattle, and goats are consistent with those 
described for other related Simbu serogroup viruses that 
infect ruminants, particularly Akabane virus and Aino 
virus.21,25–30 However, some clinical signs reported for 
Akabane, such as epizootic encephalomyelitis,31 have 
not yet been reported for Schmallenberg virus. Relatively 
little description of clinical disease has been reported for 
Sathuperi virus. The virus was first isolated in India in 
1955–1957,15 and it was then detected in Nigeria from 
the mid-1960s.12,13 The next report of Sathuperi virus 
isolation was from Japan in 1999.3 Intriguingly, none of 
these prior isolations coincided with epizootic outbreaks, 
nor were clinical signs reported from the source animals. 
Douglas virus, isolated in Australia, is another isolate 
within the Sathuperi virus species.4,32,33 Although there 
is a lack of description of clinical disease for   Douglas 
virus in ruminants, there is a report comparing the 
teratogenic potential of Akabane and Douglas viruses 
in an embryonated egg model system.34 In this system, 
Akabane infections led to clinical signs in chicks similar 
to those seen when the same virus infects ruminants in 
utero (arthrogryposis in the legs and feet, scoliosis, and 
retarded development). For Akabane disease, clinical 
signs were noted from doses of 8–300 pfu/egg, depend-
ing on the strain. In contrast, the Douglas virus only 
induced similar clinical signs when doses of 1.4 × 105 
pfu per egg were used.34
At this stage, it is unclear why Schmallenberg virus 
appears to be much more pathogenic than its closest genetic 
relatives, Sathuperi and Douglas viruses.4 It may simply 
be a case of a new virus spreading into a naïve population 
and resulting in rapid amplification and dissemination of 
the pathogen. Certainly, there is evidence that the transport 
of pregnant cattle to Akabane-endemic areas followed by 
the returning of these cattle to “naïve” areas can result in 
significant disease outbreaks.35 An alternative possibility is 
that amino acid changes in Schmallenberg virus from the 
parental Sathuperi virus have rendered it more pathogenic 
in ruminants.
Molecular biology
Although Schmallenberg virus has only been recently 
described, the Orthobunyavirus genus is one of the best 
studied genera within the Bunyaviridae family in terms of 
its molecular biology. Orthobunyaviruses have a tripartite 
negative-sense single stranded RNA genome (Figure 1A). 
The three genome segments are designated as L, which 
encodes the viral RNA-dependent RNA polymerase; M, 
which encodes the viral glycoproteins Gn and Gc and the 
nonstructural protein NSm; and S, which encodes the nucleo-
capsid protein, N, and nonstructural protein, NSs.
As a consequence of the segmented nature of the 
genome, bunyaviruses that share common replication and 
  packaging signals are able to reassort segments when coin-
fecting the same host. Indeed, based on partial sequence 
data, Schmallenberg virus was proposed to be a reassortant 
between Shamonda and Sathuperi viruses.3 More recent 
sequencing data suggest that it is Shamonda virus that is 
a reassortant between Schmallenberg virus and a third, 
uncharacterized orthobunyavirus.4 Shamonda virus, has L 
and S segments that have high levels of sequence similarity to 
Schmallenberg virus, but the M segment of Shamonda virus 
is only distantly related to the M segment of Schmallenberg 
virus.4 If this is correct, the Schmallenberg virus parent of 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
13
Schmallenberg virusVirus Adaptation and Treatment 2013:5
Shamonda virus must have been circulating in the field since 
before 1965, when Shamonda virus was isolated from cattle 
in Nigeria.8,12
Consistent with its original identification by next gen-
eration sequencing, the full genome sequence of all three 
segments of Schmallenberg virus have been published.1 
However, one of the features of bunyavirus genomes is that 
segments share conserved, complimentary terminal nucle-
otides at the 5′ and 3′ ends of the RNA segments.5,36–39 Each 
of the published terminal sequences for the Schmallenberg 
viral segments is different (Figure 1B), so it is likely that these 
sequences are either missing or extended nucleotides. Indeed, 
in order to recover the replicating Schmallenberg virus from 
cloned cDNA, Elliott et al40 found it necessary to modify the 
published sequences to include terminal nucleotides pre-
dicted from a consensus of other Simbu serogroup viruses. 
The modified Schmallenberg virus had similar growth in 
cell culture to the original, unmodified isolate, which was 
recovered in baby hamster kidney (BHK21) cells after prior 
incubation (10 days) of sonicated blood with a Culicoides 
(KC) cell line.1,40
Bunyaviruses replicate in the cytoplasm of infected cells 
and assemble in the lumen of Golgi stacks.41–45 The viral 
glycoproteins, Gn and Gc, and the nonstructural protein, 
NSm, are encoded by the mRNA segment. Gn and Gc form 
a heterodimer that is retained in the Golgi to allow virus 
assembly.46–50
There is evidence for functional interactions between 
the 5′ and 3′ end of the negative sense viral genomic RNA 
segments and for the direct interaction between these and 
the viral nucleocapsid, N, and the RNA-dependent-RNA 
polymerase, L.5,45 Transcription occurs in the cytoplasm 
and involves priming of viral transcripts using short, capped 
oligonucleotides derived from cellular mRNAs.51–55 To enable 
this cap-snatching mechanism, which is analogous to that 
employed in the nucleus by Influenza A virus, the bunyavirus 
L proteins have cap-dependent endonuclease activity.53,56 
Although there is no direct evidence for this endonuclease 
activity for the Schmallenberg virus L, the protein does con-
tain the conserved motifs associated with this activity in other 
bunyaviruses (Figure 2). Although bunyavirus transcripts are 
not polyadenylated, there is evidence from several members 
of the Bunyaviridae family that the untranslated regions of 
several bunyaviruses contain cis-acting sequences that pro-
mote efficient translation of the viral messenger-sense RNA 
in the absence of a poly-A tail.57–60
In mammalian cells, but not in vector insect cells, replica-
tion of some bunyaviruses, including Schmallenberg virus, 
results in the shut off of host cell transcription.40,61–66 This 
effect is mediated by the viral NSs protein and was initially 
characterized as a way in which bunyaviruses avoid inter-
feron and other antiviral responses that require transcription. 
Although not all bunyaviruses encode a NSs ortholog,45,67 
Schmallenberg virus does. Furthermore, the recovery of a 
Schmallenberg virus variant in which NSs is deleted resulted 
in a virus with reduced ability to shut down host cell tran-
scription and increased induction of interferon synthesis in 
infected mammalian cells.40
Spread
With relatively little data on the basic biology of Schmallenberg 
virus, beyond what can be inferred from the replication of 
other orthobunyaviruses, there have been several recent 
reviews that have focused on the identification and spread of 
the virus.2,19,20,68 Rather than repeat the detailed epidemiologi-
cal situation, which has been well covered by others, we will 
limit our discussion to the key features of the European Sch-
mallenberg virus outbreak. Firstly, the detection of the virus 
in 2011 appears to genuinely coincide with the introduction 
of Schmallenberg virus into Europe. Testing of retrospective 
samples has consistently failed to identify any cases that 
are positive by PCR or ELISA prior to 2011.1,2 Despite the 
intriguing hints from the similarity between Schmallenberg 
virus and two of the three segments of Shamonda virus noted 
1
NLC
33
33
RHDYF...TPDN...DYKVST...TYEKY...IIRADP...GEFT
RH-YF...TPDN...DYKVS
T...T--KY...IIR–DP...GEFT
37 75 78 90 95 103 107 126 131 183 185
185 2254
SBV
Consensus SF AN
V V D
Figure 2 Position and sequence of the putative cap-snatching endonuclease in Schmallenberg virus L. 
Notes: The position of the putative cap-snatching endonuclease and sequence motifs in Schmallenberg L are indicated. Amino acids in bold in this motif have been 
characterized as important for nuclease function in the La Crosse virus.56 The consensus sequence shows the variation in these sequences across the L protein of 35 other 
orthobunyavirus isolates.
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above, neither the original source of the Schmallenberg virus 
outbreak, nor the field circulation of the Schmallenberg virus 
strain outside Europe have been reported.
Secondly, spread of Schallenberg virus has been extremely 
rapid. This is consistent with the spread of the Bluetongue 
virus in northern Europe in 2006–2009.69–71 If anything, the 
spread of Schmallenberg virus has been even more rapid, 
and involves rapid spread even against the direction of the 
prevailing winds in this region. It is probably worth noting 
that in controlled infection studies in paleoarctic species of 
Culicoides in which Bluetongue virus was fed to midges, 
only 0.4%–7.4% of midges were susceptible to   infection.72 
Therefore, the increased spread of   Schmallenberg virus may 
simply be a result of more efficient uptake into the vector. 
Interestingly, the time of year with peaks of animals testing 
positive for Schmallenberg virus are consistent with those 
testing positive for Bluetongue virus in the recent Bluetongue 
virus type 8 outbreak, which further supports the hypothesis 
that Schmallenberg disease is primarily midge transmitted.2 
However, at this stage, it is not possible to rule out the pos-
sibility that other blood feeding arthropods may play a role 
in transmission of the virus.
Finally, the Schmallenberg outbreak is ongoing, with 
continued seroconversion of animals in the past year.23,73–83 
Surveys of immune responses among the camelids and 
ruminants at the Royal Veterinary College, London to the 
Schmallenberg virus have suggested that although only 3% 
of ruminants were seropositive in July 2012, whilst 62% had 
been seroconverted by November 2012 (Brownlie et al, per-
sonal communication).24 The clinical implications and repro-
ductive consequences of this are being studied further.
Future control measures
The degree of control necessary for Schmallenberg virus is 
currently unclear. The lack of clinical disease in other parts 
of the world – despite evidence from molecular reassortment 
studies that the virus has been present for some time,4,12 and 
the evidence that prior infection provides protection from 
reinfection2 – suggests that herd immunity may be one of the 
biggest factors in controlling the impact of this disease. It 
may be possible to manipulate this by vaccination, although 
currently no licensed vaccines are available. Inactivated and 
attenuated virus vaccines have been shown to be effective for 
other Simbu serogroup viruses.84–86 It is also likely that the 
Schmallenberg virus NSs knockout mutant viruses could be 
the basis for an effective vaccine.40,87 Clone 13, a naturally 
occurring NSs deletion mutant of the Rift Valley fever virus 
has been demonstrated to be an effective vaccine candidate 
in sheep and cattle.88,89 However, clone 13 contains a large 
deletion in NSs, which is possible because the nucleocapsid 
(N) and NSs genes are coded separately and in opposite direc-
tions on the S segment of the Rift Valley fever virus RNA. 
In Schmallenberg virus and other orthobunyaviruses, N and 
NSs overlap and are encoded by different initiation sites 
(start codons) in the same viral strand (Figure 1A). Therefore, 
although it is possible to knock out NSs expression through 
the insertion of stop codons or via mutation of ATG codons, 
it is not possible to delete this gene without also deleting the 
coding sequence for the essential protein, N. Schmallenberg 
virus NSs knockout mutants may, therefore, have more 
potential to revert than NSs deletion mutants for other 
bunyaviruses. This may be a serious concern for developing 
these mutants as potential vaccine candidates. As with all 
viruses with segmented genomes, there is a further compli-
cation that attenuated live virus vaccines may reassort with 
circulating field strains of the virus.
Control of bunyaviruses through the control of Culicoides 
midges seems unlikely to be effective; the midges are ,3 mm 
long, thus effective insect proof screening on livestock hous-
ing is impractical under field conditions. Furthermore, even 
cattle dung from inside cattle housing can provide sufficient 
moisture for the midge to go through its larval stages.90,91 
Insecticides and repellants could have some potential, but the 
elimination of biting in the field, or potential cervid hosts, 
would not be affected by these controls. Similarly, controls on 
the movements of affected livestock are impacted by the fact 
that Culicoides midges can be blown by wind for hundreds 
of kilometers.92 Indeed, the recent finding that wind disper-
sal of Culicoides appears to be the most significant factor 
in the 2006–2009 outbreak of Bluetongue virus (another 
Culicoides-transmitted viral disease), it may also have rel-
evance in the spread of Schmallenberg virus.93
In common with the earlier Bluetongue virus outbreaks, 
the cold winters in northern Europe do not appear to have 
been a barrier to the overwintering of Schmallenberg virus. 
Whether this is because the virus is maintained in develop-
ing fetuses over winter – which can then become the foci for 
new infections in the spring if they survive – or whether it 
overwinters by some other mechanism, such as transovarial 
transmission in Culicoides or in alternative long-lived arthro-
pods such as ticks, is currently unclear.
The long-term potential for controlling Schmallenberg 
virus will be dependent on the degree to which the virus 
can persist in wild ruminants and the availability of suitable 
vaccines. Eradication in Europe is a theoretical possibility if 
vaccines were available, but this would require a coordinated 
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vaccination program across all affected countries due to the 
rapid spread of the disease from affected areas. Whether vac-
cination is economically justified will depend on the impact 
the disease has on the production costs of European farmers, 
which have not yet been quantified.
Other threats
Although at this stage the long-term economic significance 
of Schmallenberg disease is unclear, the outbreak does 
highlight the potential of exotic arboviral diseases to spread 
rapidly into new areas. It is possible that outbreaks of two 
Culicoides midge-transmitted pathogens (Bluetongue virus 
and Schmallenberg virus) occurring within 6 years of each 
other is a coincidence; however, in the context of the separate 
and repeated incursions of bluetongue into southern Europe 
in the 8 years prior to that,70 it seems more likely that condi-
tions in Europe now favor the transmission of previously 
exotic midge-transmitted viral diseases.
Fortunately, relatively few zoonotic diseases are trans-
mitted by midges and those that are, such as Oropouche 
and Iquitos,94,95 do not generally result in life-threatening 
illnesses. Of the animal pathogens, Bluetongue virus, Afri-
can horse sickness virus, as well as the Akabane and Aino 
viruses are among the most significant in other parts of the 
world. For the Bluetongue virus and African horse sickness 
virus, both viruses exist as multiple serotypes, which do not 
confer cross-protection. Therefore, animals currently vac-
cinated against Bluetongue virus-11, Bluetongue virus-4, or 
Bluetongue virus-8 would not be protected from infection 
with any of the other 23 serotypes of Bluetongue virus in a 
future outbreak. Similarly, antibodies raised to Schmallenberg 
virus do not efficiently cross-neutralize some other Simbu 
group viruses, such as Shamonda or Sabo viruses.4
Summary
Since its initial identification by next-generation sequencing, 
Schmallenberg virus has spread rapidly through European 
domestic ruminants, causing an epizootic of congenital 
abnormalities. Current data suggest that the virus is a member 
of the species Sathuperi virus, although the severity of the 
clinical signs reported for Schmallenberg virus exceeds any 
previous Sathuperi outbreak. Controls put in place following 
the bluetongue epizootic in northern Europe in 2006–2009 
have been largely ineffective at controlling the spread of 
Schmallenberg virus infections. The most effective future 
controls, if necessary on welfare or economic grounds, are 
likely to be dependent on the development and use of   effective 
vaccines, which are a realistic possibility for this virus. It is 
likely that outbreaks of other midge-transmitted diseases will 
occur in Europe in the future, and they will be similarly resis-
tant to controls. Therefore, the development of safe, effective 
vaccines to these pathogens should be prioritized.
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